Key Highlights Scp776 is the first therapy to show clinically meaningful efficacy in late-window stroke patients (treated up to 24 hours after onset)...

Follow-up analysis from Argenica’s Phase II stroke trial shows promising functional improvements in patients treated with ARG-007. ...

Follow-up analysis from Argenica’s Phase II stroke trial shows promising functional improvements in patients treated with ARG-007. ...

High homocysteine levels pose a serious risk to heart health and brain function. This often-ignored amino acid can damage blood vessels and lead to...

High homocysteine levels pose a serious risk to heart health and brain function. This often-ignored amino acid can damage blood vessels and lead to...

Public assessments for blood pressure, blood sugar levels and stroke risk levels will be given at King Edward VII Memorial Hospital this month for...

Public assessments for blood pressure, blood sugar levels and stroke risk levels will be given at King Edward VII Memorial Hospital this month for...

THURSDAY, Oct. 9, 2025 -- The addition of sotatercept, an activin-signaling inhibitor, to background therapy results in a lower risk for clinical...

Increased grip strength correlates with lower obesity-related disease risk, suggesting muscle power as a key factor in preclinical obesity management.

A study published in the Journal of Clinical Oncology revealed that consuming tree nuts, such as almonds and walnuts, may significantly reduce the...